---
$id: https://graph.org.ai/products/commodity/51162720
$type: Product
source: UNSPSC
code: "51162720"
title: "Letosteine"
class: "51162700"
classTitle: "Decongestants, expectorants, and mucolytics"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Letosteine

**UNSPSC Code**: 51162720
**Class**: [Decongestants, expectorants, and mucolytics](Decongestants, expectorants, and mucolytics.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a mucolytic agent with the molecular formula C10H17NO4S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 6MVF9U95DW, chemically known as 4-thiazolidinecarboxylic acid, 2-(2-((2-ethoxy-2-oxoethyl)thio)ethyl)- but more generally known as letosteine, which bears US NIH Compound Identifier 68707. European Medicines Agency schedules Letosteine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08442MIG. The term LETOSTEINE is an International Non-Proprietary Name. World Health Organization schedules letosteine in its Anatomical Therapeutic Chemical (ATC) Classification. LETOSTEINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule letosteine under HS 29341000 and SITC 51579. As of Q4 2014, LETOSTEINE remains US FDA's Preferred Term for this commodity. Letosteine bears US NLM identifiers UMLS ID C0064777 and NCI Concept Code C80974. SMILES: CCOC(=O)CSCCC1NC(CS1)C(=O)O.

